Journal of the Korean Association of Oral and Maxillofacial Surgeons : eISSN 2234-5930 / pISSN 2234-7550

Table. 1.

Table. 1.

Drug distribution, standard dose, and number of patients using the drugs

Drug Dose (mg) No. of patients 3
Zolendronic acid IV 4 70
Trastuzumab IV 440 4
Pamidronate IV 90 2
Denosumab SC 60 2
Patients before medication start 1
- 6
Multiple drugs 2
- 6

(IV: intravenous, SC: subcutaneous)

1
Patients evaluated prior to medication use.

2
Associations of zoledronic acid and trastuzumab (3), zoledronic acid and pamidronate (2), zoledronic acid and gefitinib (1).

3
Six patients started medication after consultation.

J Korean Assoc Oral Maxillofac Surg 2021;47:20~24
https://doi.org/10.5125/jkaoms.2021.47.1.20
© JKAOMS